Enzo Biochem, Inc. (NYSE:ENZ) Announces $0.10 Quarterly Dividend

Enzo Biochem, Inc. (NYSE:ENZ) announced a quarterly dividend on Tuesday, October 29th,NASDAQ Dividends reports. Stockholders of record on Friday, November 15th will be paid a dividend of 0.10 per share by the medical research company on Monday, December 2nd. This represents a $0.40 annualized dividend and a dividend yield of 34.93%. The ex-dividend date is Friday, November 15th.

Enzo Biochem Stock Performance

Shares of ENZ opened at $1.15 on Thursday. The company has a 50-day moving average of $1.13 and a two-hundred day moving average of $1.12. Enzo Biochem has a 12-month low of $0.99 and a 12-month high of $1.50.

Analyst Upgrades and Downgrades

Separately, StockNews.com started coverage on shares of Enzo Biochem in a report on Thursday, November 7th. They issued a “hold” rating on the stock.

About Enzo Biochem

Enzo Biochem, Inc develops, manufactures, and markets products and tools for clinical research, translational research, drug development, and bioscience research customers worldwide. The company offers proteins, antibodies, peptides, small molecules, labeling probes, dyes, and kits, which provide life science researchers tools for target identification/validation, content analysis, gene expression analysis, nucleic acid detection, protein biochemistry and detection, and cellular analysis.